Yoshinao Kobayashi

Yoshinao Kobayashi

Auto-generated profile, based on publicly available information

Yoshinao Kobayashi

Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in eLife
Verified
Journal Article
Open access
YTYasuyuki Tamai
Yasuyuki Tamai
AEAkiko Eguchi
Akiko Eguchi
RSRyuta Shigefuku
Ryuta Shigefuku
HKHiroshi Kitamura
Hiroshi Kitamura
MTMina Tempaku
Mina Tempaku
HNHayato Nakagawa
Hayato Nakagawa
Background: Hepatic sarcopenia is one of many complications associated with chronic liver disease (CLD) and has a high mortality rate; however, the liver-muscle axis is not fully understood. Therefore, few effective treatments exist for hepatic sarcopenia, the best of which being branched-chain amino acid (BCAA) supplementation to help increase muscle mass. Our aim was to investigate the molecular mechanism(s) of hepatic sarcopenia focused on bile acid (BA) composition.Methods: The correlation between serum BA levels and psoas muscle mass index (PMI) was examined in 73 CLD patients. Gastrocnemius muscle phenotype and serum BA levels were assessed in CLD rats treated with BCAA. Mouse skeletal muscle cells (C2C12) were incubated with lithocholic acid (LCA), G-protein-coupled receptor 5 (TGR5) agonist or TGR5 antagonist to assess skeletal muscle hypertrophy.Results: In human CLD, serum LCA levels were the sole factor positively correlated with PMI and were significantly decreased in both the low muscle mass group and the deceased group. Serum LCA levels were also shown to predict patient survival. Gastrocnemius muscle weight significantly increased in CLD rats treated with BCAA via suppression of protein degradation pathways, coupled with a significant increase in serum LCA levels. LCA treated C2C12 hypertrophy occurred in a concentration-dependent manner linked with TGR5-Akt pathways based upon inhibition results via a TGR5 antagonist.Conclusions: Our results indicate LCA-mediated skeletal muscle hypertrophy via activation of TGR5-IGF1-Akt signaling pathways. In addition, serum LCA levels were associated with skeletal muscle mass in cirrhotic rats, as well as CLD patients, and predicted overall patient survival.Funding: This research was supported by JSPS KAKENHI Grant Number 22K08011 and 21H02892, and AMED under Grant Number JP21fk0210090 and JP22fk0210115. Maintaining cirrhotic rats were partially supported by Otsuka Pharmaceutical Company.

1 September 2012 in Journal of Applied Physics
Verified
Journal Article
Closed access
PDF file
RLRui Lan
Rui Lan
RERie Endo
Rie Endo
MKMasashi Kuwahara
Masashi Kuwahara
YKYoshinao Kobayashi
Yoshinao Kobayashi
MSMasahiro Susa
Masahiro Susa
GeTe alloy has drawn much attention as one of the promising candidates for phase change memory application. In this work, the electrical resistivities and thermal conductivities of GeTe alloy have been determined as functions of temperature by the four-terminal method and hot strip method, respectively. The electrical resistivity increases and the thermal conductivity decreases monotonically with increasing temperature, and thus it is likely that free electron dominates the thermal conduction. The electrical resistivity increases slowly with time during holding at 773 K, and the thermal conductivity decreases corresponding to the change of the electrical resistivity, which suggests that small amount of high temperature phase might exist in the samples.

1 March 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YTYasuyuki Tamai
Yasuyuki Tamai
Zhen ChenZhen Chen
Zhen Chen
YWYue Wu
Yue Wu
JOJun Okabe
Jun Okabe
YKYoshinao Kobayashi
Yoshinao Kobayashi
YTYoshiyuki Takei
Yoshiyuki Takei
Branched-chain amino acids (BCAA) reverse malnutrition and l-carnitine leads to the reduction of hyperammonemia and muscle cramps in cirrhotic patients. BCAA and l-carnitine are involved in glucose and fatty acid metabolism, however their mechanistic activity in cirrhotic liver is not fully understood. We aim to define the molecular mechanism(s) and combined effects of BCAA and l-carnitine using a cirrhotic rat model. Rats were administered carbon tetrachloride for 10 weeks to induce cirrhosis. During the last 6 weeks of administration, cirrhotic rats received BCAA, l-carnitine or a combination of BCAA and l-carnitine daily via gavage. We found that BCAA and l-carnitine treatments significantly improved hepatocellular function associated with reduced triglyceride level, lipid deposition and adipophilin expression, in cirrhotic liver. Lipidomic analysis revealed dynamic changes in hepatic lipid composition by BCAA and l-carnitine administrations. BCAA and l-carnitine globally increased molecular species of phosphatidylcholine. Liver triacylglycerol and phosphatidylcholine hydroperoxides were significantly decreased by BCAA and l-carnitine. Furthermore, serum and liver ATP levels were significantly increased in all treatments, which were attributed to the elevation of mature cardiolipins and mitochondrial component gene expressions. Finally, BCAA and l-carnitine dramatically reduced hepatocellular death. In conclusion, BCAA and l-carnitine treatments attenuate hepatocellular damage through the reduction of lipid peroxides and the overall maintenance of mitochondrial integrity within the cirrhotic liver. These effectiveness of BCAA and l-carnitine support the therapeutic strategies in human chronic liver diseases.


1 January 1996 in ISIJ International
Verified
Journal Article
Open access
YKYoshinao Kobayashi
Yoshinao Kobayashi
KMKazuki Morita
Kazuki Morita
NSNobuo Sano
Nobuo Sano

23 December 2004 in Hepatology
Verified
Journal Article
Open access
PDF file
MIMotoh Iwasa
Motoh Iwasa
MNMakoto Nakao
Makoto Nakao
YKYoshiaki Kato
Yoshiaki Kato
YKYoshinao Kobayashi
Yoshinao Kobayashi
KTKenji Takagi
Kenji Takagi
YAYukihiko Adaci
Yukihiko Adaci
Click on the article title to read more.